Actively Recruiting

Phase 3
Age: 18Years +
All Genders
ID07388498

A Phase 3, Multicenter, Double-blind, Randomized Controlled Study Evaluating Pegloticase by Subcutaneous Injection Versus Intravenous Injection with Methotrexate in Adults with Uncontrolled Gout

Led by Amgen · Updated on 2026-05-04

270

Participants Needed

37

Research Sites

8 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

This trial focuses on adults with uncontrolled gout, investigating the effects of pegloticase given with methotrexate (MTX). Researchers aim to compare two ways of delivering pegloticase: subcutaneous (under the skin) and intravenous (into a vein). The main goal is to see how well each method maintains normal levels of serum uric acid during the sixth month of treatment. Participants will be randomly assigned to receive either pegloticase 18 mg by subcutaneous injection every two weeks with MTX or pegloticase 8 mg by intravenous infusion every two weeks with MTX. MTX is taken orally weekly. Both groups are monitored under a double-blind design, meaning neither participants nor researchers know which treatment is given to ensure unbiased results. During the study, participants will have their serum uric acid levels checked regularly, especially at weeks 20 through 24 to assess response. Researchers will also monitor for serious injection site reactions and infusion reactions, including anaphylaxis, up to week 48. The study includes assessments of drug levels in the blood and safety monitoring throughout. Participation lasts at least six months with ongoing evaluations to track efficacy and safety.

CONDITIONS

Brief Title

A Double-blind, Randomized Controlled Trial to Investigate the Efficacy, Safety, and Pharmacokinetics of Pegloticase Administration Via Subcutaneous and Intravenous Routes Both With Methotrexate in Participants With Uncontrolled Gout

Who Can Participate

Age: 18Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Participant has provided informed consent before any trial-specific activities.
  • Age 18 years or older (or legal age in country if older than 18).
  • Willing and able to follow the treatment plan and evaluations for the trial duration.
  • Diagnosis of uncontrolled gout meeting protocol criteria.
Not Eligible

You will not qualify if you...

  • Glucose-6-phosphate dehydrogenase deficiency.
  • Liver enzyme levels (AST or ALT) greater than 1.25 times the upper limit of normal or low albumin at screening.
  • Uncontrolled diabetes or hemoglobin A1c above 8%.
  • Known intolerance to methotrexate.
  • Prior treatment with pegloticase, other recombinant uricase drugs, or PEG-conjugated drugs.
  • Intolerance to all standard gout flare prevention treatments (colchicine, NSAIDs, or low-dose corticosteroids).
  • Severe chronic kidney impairment (eGFR below 40 mL/min/1.73 m²) or on dialysis.

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Your Study Journey

Screening

Duration - 2 to 4 weeks

Participants are screened for eligibility to participate in the trial.

1 visit (in-person)

Treatment

Duration - Up to 24 weeks

Participants receive pegloticase either by subcutaneous injection or intravenous infusion every two weeks, along with oral methotrexate.

Biweekly visits for treatment administration

Follow-up

Duration - Up to 24 weeks after treatment

Participants are monitored for safety and pharmacokinetics after completing treatment.

Visits as scheduled for safety assessments up to Week 48

Trial Site Locations

Total: 37 locations

1

Solace Clinical Research

Tustin, California, United States, 92780

Actively Recruiting

2

Denver Arthritis Clinic PC

Denver, Colorado, United States, 80230

Actively Recruiting

3

D and H Pompano Research Center

Aventura, Florida, United States, 33180

Actively Recruiting

4

New Generation of Medical Research

Hialeah, Florida, United States, 33016

Actively Recruiting

5

Homestead Associates In Research Inc

Homestead, Florida, United States, 33033

Actively Recruiting

6

Well Pharma Medical Research Corp

Miami, Florida, United States, 33143

Actively Recruiting

7

D and H National Research Centers

Miami, Florida, United States, 33155

Actively Recruiting

8

Advanced Clinical Research

Miami, Florida, United States, 33156

Actively Recruiting

9

Felicidad Medical Research

Miami, Florida, United States, 33184

Actively Recruiting

10

Decision Management International Research

Pinellas Park, Florida, United States, 33782

Actively Recruiting

11

Integral Rheumatology and Immunology Specialists

Plantation, Florida, United States, 33324

Actively Recruiting

12

D and H Tamarac Research Center

Tamarac, Florida, United States, 33321

Actively Recruiting

13

GCP Clinical Research, LLC

Tampa, Florida, United States, 33609

Actively Recruiting

14

ClinPro Research Solutions LLC

Tampa, Florida, United States, 33613

Actively Recruiting

15

Conquest Research - Winter Park

Winter Park, Florida, United States, 32789

Actively Recruiting

16

Spatium Urgent Care

Marietta, Georgia, United States, 30066

Actively Recruiting

17

Vista Clinical Research

Newnan, Georgia, United States, 30265

Actively Recruiting

18

Charter Research

Chicago, Illinois, United States, 60618

Actively Recruiting

19

Flourish Research Ravenswood

Chicago, Illinois, United States, 60640

Actively Recruiting

20

Greater Chicago Specialty Physicians

Schaumburg, Illinois, United States, 60195

Actively Recruiting

21

Willow Rheumatology and Wellness

Willowbrook, Illinois, United States, 60527

Actively Recruiting

22

Kur Research at Columbia Medical Practice

Columbia, Maryland, United States, 21045

Actively Recruiting

23

MD Medical Research

Oxon Hill, Maryland, United States, 20745

Actively Recruiting

24

Buffalo Rheumatology and Medicine

Orchard Park, New York, United States, 14127

Actively Recruiting

25

Joint and Muscle Research Institute

Charlotte, North Carolina, United States, 28204

Actively Recruiting

26

Cape Fear Arthritis Care, PLLC

Leland, North Carolina, United States, 28451

Actively Recruiting

27

Accellacare Salisbury

Salisbury, North Carolina, United States, 28144

Actively Recruiting

28

Carolina Research Center Inc

Shelby, North Carolina, United States, 28150

Actively Recruiting

29

Shelby Clinical Research

Shelby, North Carolina, United States, 28150

Actively Recruiting

30

Paramount Medical Research and Consulting LLC

Middleburg Heights, Ohio, United States, 44130

Actively Recruiting

31

Altoona Center for Clinical Research

Duncansville, Pennsylvania, United States, 16635

Actively Recruiting

32

Articularis Healthcare Group Inc dba Low Country Rheumatology

Summerville, South Carolina, United States, 29486

Actively Recruiting

33

Pioneer Research Solutions Inc

Houston, Texas, United States, 77099

Actively Recruiting

34

Epic Clinical Research

Lewisville, Texas, United States, 75057

Actively Recruiting

35

Be Well Clinical Studies

Round Rock, Texas, United States, 78681

Actively Recruiting

36

Overlake Arthritis and Osteoperosis Center

Bellevue, Washington, United States, 98004

Actively Recruiting

37

Caribbean Health Research Center

San Juan, Puerto Rico, 00917

Actively Recruiting

Loading map...

Research Team

A

Amgen Call Center

How is the study designed?

Study Type

INTERVENTIONAL

Masking

DOUBLE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

TREATMENT

Number of Arms

2

Frequently Asked Questions

Have more questions? Get in touch with our team for quick support

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here